Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: Conformational characterization and interaction with kringle domains

Protein Science

Volumn 7, Issue 9, 1998, Pages 1947-1959

  An, Seong Soo A ^a   Marti, Daniel N ^a   Carreño, Cristina ^b   Albericio, Fernando ^b   Schaller, Johann ^c   Llinas, Miguel ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Kringle domains; Plasminogen activation peptide; Plasminogen N terminal peptide; Preactivation peptide structure

Indexed keywords

AMINO ACID; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; ISOLEUCINE; LYSINE; PLASMINOGEN; SERINE; VALINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; HUMAN; KRINGLE DOMAIN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0001308901     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070910     Document Type: Article

References (112)

1. Albericio F, Kneib-Cordonier N, Biancalana S, Gera L, Masada RI, Hudson D, Barany G. 1990. Preparation and application of the 5-[[(4-Fmoc-amino)methyl]-3:5-dimethoxy-phenoxy] valeric acid (PAL) handle for the solid-phase synthesis of C-terminal peptide amides under mild conditions. J Org Chem 55:3730-3743.
2. An SSA, Carreño C, Albericio F, Marti D, Schaller J, Llinás M. 1998. Lysine-50 is a likely site for anchoring the plasminogen N-terminal domain to lysine-binding kringles. Protein Sci 7:1960-1969.
3. Andreu D, Albericio F, Solé NA, Munson MC, Ferrer M, Barany G. 1994. Peptide synthesis protocols. In: Pennington MW, Dunn BM, eds. Methods in molecular biology, Vol 35. Totowa, NJ: Humana Press. pp 91-169.
4. Aue WP, Bartholdi E, Ernst RR. 1976. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J Chem Phys 64:2229-2246.
5. Balciunas A, Fless GM, Scanu AM, Copeland RA. 1993. Interactions of a fluorescently labeled peptide with kringle domains in proteins. J Protein Chem 12:39-43.
6. Bányai L, Patthy L. 1984. Importance of intramolecular interactions in the control of fibrin affinity and activation of human plasminogen. J Biol Chem 259:6466-6471.
7. 1H-NMR spectra via two-dimensional homonuclear Hartman-Hahn spectroscopy. J Am Chem Soc 107:2820-2822.
8. Bidlingmeyer BA, Cohen SA, Tarvin TL. 1984. Rapid analysis of amino acids using pre-column derivatization. J Chromatogr 336:93-104.
9. 1H NMR characterization of the urokinase kringle module: Structural but not functional, relatedness to homologous domains. J Biol Chem 268:13858-13868.
10. Braunschweiler L, Ernst RR. 1983. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J Magn Reson 55:521-528.
11. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. 1983. CHARMM: A program for macromolecular energy minimization & dynamics calculations. J Comput Chem 4:187-217.
12. Brünger AT. 1992. X-PLOR version 3.0 user manual. New Haven. CT: Yale University Press.
13. Bruschweiler R, Blackledge M, Ernst RR. 1991. Multi-conformational peptide dynamics derived from NMR data: A new search algorithm and its application to antanamide. J Biomol NMR 1:3-11.
14. 1H-NMR. Biochemistry 34:2739-2750.
15. Byeon IJ, Llinás M. 1991. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid, an antifibrinolytic drug. J Mol Biol 222:1035-1051.
16. Castellino FJ, Brockway WJ, Thomas JK, Liao HT, Rawitch AB. 1973. Rotational diffusion analysis of the conformational alterations produced in plasminogen by certain antifibrinolytic amino acids. Biochemistry 12:2787-2791.
17. Castellino FJ, Urano T, de Serrano VS, Beals JM. 1990. The structure and activation of human plasminogen. In: Scanu AM, ed. Lipoproteins. San Diego, CA: Academic Press. pp 87-101.
18. Chang JY, Knecht R. 1991. Direct analysis of the disulfide content of proteins: Methods for monitoring the stability and refolding process of cystine-containing proteins. Anal Biochem 197:52-58.
19. Christensen U. 1984. The AH-site of plasminogen and two C-terminal fragments: A weak lysine binding site preferring ligands not carrying a free carboxylate function. J Biol Chem 223:413-421.
20. Claeys H, Vermylen J. 1974. Physical-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogens: Influence of 6-aminohexanoic acid. Biochim Biophys Acta 342:351-359.
21. 1H-NMR analysis of horse plasminogen kringle 4. Chem Phys Lipids 67/68:43-58.
22. De Marco A. 1977. pH dependence if internal references. J Magn Reson 26:527-528.
23. 1H-NMR spectra of Ferrichrome peptides. II. The amide resonances. Biopolymers 17:637-650.
24. Danø K, Andreasen PA, Grøndahl-Hansen J. 1985. Plasminogen activators, tissue degradation, cancer. Adv Cancer Res 44:139-266.
25. Danø K, Behrendt M, Brünner N, Ellis V, Ploug M, Pyke C. 1994. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8:189-203.
26. De Serrano VS, Castellino FJ. 1992a. Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its ω-amino acid binding properties. Biochemistry 31:3326-3335.
27. De Serrano VS, Castellino FJ. 1992b. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with ω-amino acids. Biochemistry 31:11698-11706.
28. De Serrano VS, Castellino FJ. 1993. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with ω-amino acid ligands. Biochemistry 32:3540-3548.
29. De Serrano VS, Castellino FJ. 1994. Role of the strictly conserved tryptophan-25 residue in the stabilization of the structure and in the ligand binding properties of the kringle 2 domain of tissue-type plasminogen activator. Biochemistry 33:1340-1344.
30. De Serrano VS, Sehl LC, Castellino FA. 1992. Direct identification of lysine-33 as the principal cationic center of the ω-amino acid binding site of the recombinant kringle 2 domain of tissue-type plasminogen activator. Arch Biochem Biophys 292:206-212.
31. Deutsch DG, Mertz ET. 1970. Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095-1096.
32. De Vlieg J, Boelens R, Scheek RM, Kaptein R, van Gunsteren WF. 1986. Restrained molecular dynamics procedure for protein tertiary structure determination from NMR data: A lac repressor headpiece structure based on information on J-coupling and from presence and absence of NOEs. Isr J Chem 27:181-188.
33. de Vos AM, Ultsch MH, Kelley RF, Padmanabhan K, Tulinsky A, Westbrook ML, Kossiakoff AA. 1992. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-Å resolution. Biochemistry 31:270-279.
34. Forsgren M, Råden B, Israelsson M, Larsson K, Hedén LO. 1987. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett 213:254-260.
35. Gehrmann M. 1996. Expression, Isolation und Charakterisierung des Präaktivierungspeptids (PAP) von humanem Plasminogen [Diplomarbeit]. Berne, Switzerland: University of Berne.
36. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. 1989. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86:5844-5848.
37. Glasoe PK, Long FA. 1960. Use of glass electrode to measure acidities in deuterium oxide. J Phys Chem 64:188-190.
38. González-Gronow M, Violand BN, Castellino FJ. 1977. Purification and some properties of the Glu-and Lys-human plasmin heavy chains. J Biol Chem 252:2175-2177.
39. Han S, Friezner-Degen SJ. 1993. Genomic organization, chromosomal localization and developmental expression of HGF-like protein. In: Goldberg ID, Rosen EM, eds. Hepatocyte growth factor-scatter factor (HGF-SF) and the C-Met receptor. Berlin: Birkhäuser. pp 81-106.
40. Hochschwender SM, Laursen RA. 1981. The lysine binding sites of human plasminogen: Evidence for a critical tryptophan in the binding site of kringle 4. J Biol Chem 256:11172-11176.
41. Holley LH, Karplus M. 1991. Neural networks for protein structure prediction. Methods Enzymol 202:204-224.
42. Hoover GJ, Menhart N, Martin A, Warder S, Castellino FJ. 1993. Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with ω-amino acids. Biochemistry 32:10936-10943.
43. Horrevoets AJG, Smilde AE, Fredenburgh JC, Pannekoek H, Nesheim ME. 1995. The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the amino-terminal hinge region. J Biol Chem 270:15770-15776.
44. Hunkapiller MW, Lujan E, Ostrander F, Hood LE. 1983. Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods Enzymol 91:227-236.
45. Ichinose A. 1992. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 31:3113-3118.
46. Lerch PG, Rickli EE. 1980. Studies on the chemical nature of lysine-binding sites and on their localization in human plasminogen. Biochim Biophys Acta 625:374-378.
47. Lerch PG, Rickli EE, Lergier W, Gillessen D. 1980. Localization f individual lysine binding regions in human plasminogen and investigation on their complex-forming properties. Eur J Biochem 107:7-13.
48. 1H-NMR study of isolated domains from human plasminogen: Structural homology between kringles 1 and 4. Eur J Biochem 135:379-391.
49. Mangel WF, Lin B, Ramakrishnan V. 1990. Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science 248: 69-73.
50. 1H spin-spin coupling constant in proteins. Biochem Biophys Res Commun 113:967-978.
51. Markus G. 1996. Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates - A review. Fibrinolysis 10:75-85.
52. Markus G, Evers JL, Hohika GH. 1978. Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. J Biol Chem 253:733-739.
53. Markus G, Priore RL, Wissler FC. 1979. The binding tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem 254:1211-1216.
54. Marshall JM, Brown AJ, Ponting CP. 1994. Conformational studies of human plasminogen and plasminogen fragments: Evidence for a novel third conformation of plasminogen. Biochemistry 33:3599-3606.
55. Marti D. 1994. Expression in Escherichia coli, Isolierung und Charakterisierung der rekombinanten Kringel 1 und Kringel 2 Domänen aus humanem Plasminogen und Nachweis einer schwachen Bindungsstelle für ω-Aminocarbonsäuren in Kringel 2 [Dissertation]. Berne, Switzerland: University of Berne.
56. 1H-NMR. Biochemistry 36:11591-11604.
57. Marti D, Schaller J, Ochensberger B, Rickli EE. 1994. Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for ω-aminocarboxylic acids. Eur J Biochem 219:455-462.
58. Mathews II, Vanderhoff-Hanaver P, Castellino FJ, Tulinsky A. 1996. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands ε-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic acid. Biochemistry 35:2567-2576.
59. Matsuka YV, Novokhatny VV, Kudinov SA. 1990. Fluorescence spectroscopic analysis of ligand binding to kringle 1 + 2 + 3 and kringle 1 fragments from human plasminogen. Eur J Biochem 190:93-97.
60. McCance SG, Castellino FJ. 1995. Contributions of individual kringle domains toward maintenance of the chloride-induced tight conformation of human glutamic acid-1 plasminogen. Biochemistry 34:9581-9586.
61. McCance SG, Menhart N, Castellino FJ. 1994. Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with ω-amino acid ligands. J Biol Chem 269:32405-32410.
62. Menhart N, Hoover GJ, McCance SG, Castellino FJ. 1995. Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation. Biochemistry 34:1482-1488.
63. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K. 1989. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163:967-973.
64. Motta A, Laursen R, Llinás M, Tulinsky A, Park CH. 1987. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: Structure of the ligand-binding site. Biochemistry 26:3827-3836.
65. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
66. Nielsen PR, Einer-Jensen K, Holtet TL, Andersen BD, Poulsen FM, Thørgersen HC. 1993. Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solution. Biochemistry 32:13019-13025.
67. Nilges M, Clore GM, Gronenborn AM. 1988a. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding. FEBS Lett 239:129-136.
68. Nilges M, Clore GM, Gronenborn AM. 1988b. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett 229:317-324.
69. Novokhatny VV, Matsuka YV, Kudinov SA. 1989. Analysis of ligand binding to kringles 4 and 5 fragments from human plasminogen. Thrombosis Res 53:243-252.
70. Ötting G, Liepinsh E, Wüthrich K. 1993. Disulfide bond isomerization in BPTI and BPTI(G36S): An NMR study of correlated mobility in proteins. Biochemistry 32:3571-3582.
71. Pardi A, Galdes A, Florance J, Maniconte D. 1989. Solution structures of alpha-conotoxin G1 determined by two-dimensional NMR spectroscopy. Biochemistry 28:5494-5501.
72. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4. Biochemistry 28:1368-1376.
73. Ponting CP, Holland SK, Cederholm-Williams SA, Marshall JM, Brown AJ, Spraggon G, Blake CCF. 1992a. The compact domain conformation of human Glu-plasminogen in solution. Biochim Biophys Acta 1159:155-161.
74. Ponting CP, Marshall JM, Cederholm-Williams SA. 1992b. Plasminogen: A structural review. Blood Coag Fibrinolysis 3:605-614.
75. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. 1986. Numerical recipes: The art of scientific computing. New York: Cambridge University Press: 526 pp.
76. Ramakrishnan V, Patthy L, Mangel WF. 1991. Conformation of Lys-plasminogen and the kringle 1-3 fragment of plasminogen analyzed by small-angle neutron scattering. Biochemistry 30:3963-3969.
77. Ramesh V, Petros AM, Llinás M, Tulinsky A, Park CH. 1987. Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen: The structure of the binding site. J Mol Biol 198:481-498.
78. Ramesh V, Rajan N, Laursen RC, Llinás M. 1995. Plasminogen kringle 4 binds the heptapeptide fragment 44-50 of the plasminogen N-terminal peptide. Blood Coag Fibrinolysis 6:207-218.
79. Rejante MR. 1992. Proton NMR studies on the structure and ligand-binding properties of human plasminogen kringles 1 and 4 [Dissertation]. Pittsburgh, Pennsylvania: Carnegie Mellon University.
80. Rejante MR, Byeon IJL, Llinás M. 1991. Ligand specificity of human plasminogen kringle 4. Biochemistry 30:11081-11092.
81. Rejante MR, Llinás M. 1994. Solution structure of the ε-aminohexanoic acid complex of human plasminogen kringle 1. Eur J Biochem 221:939-949.
82. Ryan TJ, Keegan MC. 1985. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin. Biochim Biophys Acta 830:187-194.
83. Sjöholm I, Wiman B, Wallén P. 1973. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. Eur J Biochem 39:471-479.
84. Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E, Leonard EJ. 1991. Macrophage stimulating protein: Purification, partial amino acid sequence, and cellular activity. J Exp Med 173:1227-1234.
85. Sodetz JM, Brockway WJ, Mann KG, Castellino FJ. 1974. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide. Biochem Biophy Res Commun 60:729-736.
86. 1H NMR characteristics of the kringle (2 + 3) supermodule: Spectroscopic/functional individuality of plasminogen kringle domains. Biochemistry 35:2357-2364.
87. Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. 1978. The primary structure of human plasminogen: Isolation of two lysine-binding fragments & one 'mini'-plasminogen (MW 38,000) by elastase-catalyzed-specific limited proteolysis. Prog Chem Fibrinolysis Thrombosis 3:191-209.
88. Sowdhamini R, Ramakrishnan C, Balaram P. 1993. Modelling multiple disulfide loop containing polypeptides by random conformation generation. The test cases of α-conotoxin GI and endothelin I. Protein Eng 6:873-882.
89. States DJ, Haberkorn RA, Ruben DJ. 1982. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J Mag Reson 48:286-292.
90. Stephens RW, Bokman AM, Myohanen HT, Reisberg T, Tapiovaara H, Pedersen N, Grøndahl-Hansen J, Llinás M. Vaheri A. 1992. Heparin binding to the urokinase kringle domain. Biochemistry 31:7572-7579.
91. 1H-NMR spectroscopy and distance geometry calculations. Protein Eng 4:509-518.
92. 1H-NMR spectroscopy. J Biol Chem 265:3906-3915.
93. Thewes T, Ramesh V, Simplaceanu EL, Llinás M. 1987. Isolation, purification & H-NMR characterization of a kringle 5 domain fragment from human plasminogen. Biochim Biophys Acta 912:254-269.
94. Tranqui L, Prandini MH, Chapel A. 1979. The structure of plasminogen studied by electron microscopy. Biologie Cellul 34:39-42.
95. Trexler M, Váli Z, Patthy L. 1982. Structure of the ω-aminocarboxylic acid-binding sites of human plasminogen: Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. J Biol Chem 257:7401-7406.
96. Tulinsky A, Park CH, Mao B, Llinás M. 1988. Lysine/fibrin binding sites of kringles modelled after the structure of kringle 1 of prothrombin. Proteins Struct Funct Genet 3:85-96.
97. Váli Z, Patthy L. 1982. Location of the intermediate and high affinity ω-aminocarboxylic acid-binding sites in human plasminogen. J Biol Chem 257:2104-2110.
98. Váli A, Patthy L. 1984. The fibrin-binding site of human plasminogen: Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. J Biol Chem 259:13690-13694.
99. Verevka SV, Kudinov SA, Grinenko TV. 1986. Arginyl-binding sites of human plasminogen. Thrombosis Res 41:689-698.
100. Violand BN, Sodetz JM, Castellino FJ. 1975. The effect of ε-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys 170:300-305.
101. Wallén P. 1980. Biochemistry of plasminogen. In: Kline DL, Reddy KNN, eds. Fibrinolysis. Boca Ratón, FL: CRC Press. pp 1-24.
102. Walther PJ, Steinman HM, Hill RL, McKee PA. 1974. Activation of plasminogen by urokinase: Partial characterization of a pre-activation peptide. J Biol Chem 249:1173-1181.
103. Weisel JW, Nagaswami C, Korsholm B, Petersen LC, Suenson E. 1994. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. J Mol Biol 235:1117-1135.
104. Weissbach L, Treadwell BV. 1992. A plasminogen-related gene is expressed in cancer cells. Biochem Biophys Res Commun 186:1108-1114.
105. 1H NMR of proteins: Experimental procedures. J Mag Res 56:207-234.
106. Wiman B. 1973. Primary structure of peptides released during activation of human plasminogen by urokinase. Eur J Biochem 39:1-9.
107. Wiman B. 1977. Primary structure of the B-chain of human plasmin. Eur J Biochem 76:129-137.
108. 2-terminal activation peptide as studied by affinity chromatography. Eur J Biochem 50:489-494.
109. Wishart DS, Sykes BD, Richards FM. 1991. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 222:311-333.
110. Wishart DS, Sykes BD, Richards FM. 1992. The chemical shift index: A fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
111. Wu TP, Padmanabhan K, Tulinsky A, Mulichak AM. 1991. The refined structure of the ε-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry 30:10589-10594.
112. Zalipsky S, Chang JL, Albericio F, Barany G. 1994. Preparation and applications of polyethylene glycol-polystyrene graft resin supports for solid-phase peptide synthesis. React Polymers 22:243-258.